Immune-cell-guided nanozymes: redefining targeted therapy for neuroinflammation in multiple sclerosis. Tariq M, Huma S, Talha M, Fatima M Ann Med Surg (Lond). 2026 May; 88(5):2988-2989. PMID: 42078638. Abstract CommentRecommendBookmarkWatch